# Tamas Hickish

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tamas-hickish/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,082 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 58 |
| i10-index | 134 |
| Last Known Institution | Dorset HealthCare University NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5027160662 |
| ORCID iD | https://orcid.org/0000-0001-6770-7279 |
| Works | 283 |

## Researcher papers

- [First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials](https://scholariq.org/papers/first-line-selective-internal-radiotherapy-plus-chemotherapy-versus-chemotherapy/)
- [A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)](https://scholariq.org/papers/a-phase-ii-study-in-advanced-gastro-esophageal-cancer-using-epirubicin-and/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Researcher university

- [Dorset HealthCare University NHS Foundation Trust](https://scholariq.org/institutions/dorset-healthcare-university-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.